Clinical Trials Sponsored by Dana-Farber Cancer Institute/Brigham and Women¹s Cancer Center and Massachusetts General Hospital Ca
Total 168 results
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedHeart FailureUnited States, Canada
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedNasopharyngeal CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedEarly-Stage Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedStomach Cancer | Gastric Cancer | Gastro-esophageal Junction CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNeoplasm Metastasis | Colorectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedCervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedPancreatic CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalCompletedOvarian Cancer | Peritoneal Carcinoma | Tubal CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedAdenocarcinoma of Stomach | Adenocarcinoma of GE Junction | Adenocarcinoma of EsophagusUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedNon-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalActive, not recruitingSmoking Cessation | Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's HospitalTerminatedRectal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompletedColorectal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; AbbottCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Pharmacia; Brigham and Women's HospitalCompletedEsophageal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Brigham and Women's HospitalCompletedMyelofibrosis | Chronic Myelomonocytic Leukemia | Myeloid Metaplasia | Agnogenic Myeloid MetaplasiaUnited States
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedGlioblastoma | Brain TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedBreast Cancer | Hodgkin's DiseaseUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedSquamous Cell Carcinoma | Carcinoma of Head/NeckUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedMixed Mullerian Tumors of the UterusUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; AstraZeneca; Brigham and Women's HospitalCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; AstraZeneca; Brigham and Women's HospitalCompletedMetastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Massachusetts General Hospital; Brigham and...CompletedHodgkin Lymphoma | Non-hodgkin LymphomaUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Brigham and Women...CompletedSolid Tumor | Liver MetastasesUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Massachusetts General Hospital; Brigham and...CompletedNasopharyngeal CarcinomaUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Brigham and Women...CompletedCholangiocarcinoma | Hepatocellular Cancer | Hepatic Metastases
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; Pharmacyclics LLC.Completed
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; Amgen; H. Lee Moffitt...CompletedNeuroendocrine Tumor | Carcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...Active, not recruitingLung CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalActive, not recruitingCAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerGastric Cancer | Esophageal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-Small-Cell Lung CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Genentech, Inc.; Brigham and Women's HospitalCompletedStomach Cancer | Esophageal CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...Active, not recruitingDuctal Carcinoma in Situ of the BreastUnited States